Abbott Laboratories ABT
109.40 USD -0.76 (-0.69%)
At closeNov 3, 2026, 4:42 PM EST
109.40 0.00 0.00%
After hours · Nov 3, 4:42 PM ET
108.94 Day range 110.60
81.97 52-week range 132.03
- YTD
- -12.68%
- 1 year
- -11.66%
Analyst view
Consensus: buy
Buy
Price target (mean) 118.52 +8.3% upside
Now 109.40
- Target (low)
- 100.00
- Target (mean)
- 118.52
- Target (high)
- 130.00
Ratings (0m) 28 23 buy · 5 hold · 0 sell
- Strong buy5
- Buy18
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 27
- 3 months ago 27
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.64 | 1.63 – 1.64 | 1.50 | +9.2% | 13.23B | +15.4% | 23 |
| Next quarter | 1.23 | 1.20 – 1.28 | 1.15 | +7.0% | 12.58B | +12.7% | 18 |
| Current year | 5.52 | 5.49 – 5.54 | 5.15 | +7.2% | 49.96B | +12.7% | 27 |
| Next year | 5.94 | 5.89 – 6.08 | 5.52 | +7.6% | 53.53B | +7.1% | 27 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Argus Research | Downgrade | Buy | Hold |
| Oct 23, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 22, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 22, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 22, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 22, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 16, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 2, 2026 | Rothschild & Co | Upgrade | Neutral | Buy |
| Sep 8, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 25, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 14, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 13, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Jul 28, 2026 | UBS | Maintained | Buy | Buy |
| Jul 17, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 17, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jul 17, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 17, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 17, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Jul 17, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 17, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 17, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 1, 2026 | Baird | Initiated | — | Outperform |
| Jun 22, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| May 31, 2026 | Goldman Sachs | Maintained | Buy | Buy |
